Vibrant Biomedicines

KALA BIO

Mineralys Therapeutics

Spero Therapeutics

Rezo Therapeutics

Pulmocide

Progyny

Odyssey Therapeutics

Nimbus

Mirobio

Fore Biotherapeutics

eFFECTOR

Dren Bio

CRISPR Therapeutics

BioTheryX

Bicycle Therapeutics

Arcellx

A biotechnology venture capital firm, partnering with founders and entrepreneurs to translate innovative science into medicines.

Tranquis Therapeutics

Nkarta Inc.

ARS Pharma

Akamis Bio

Ancora Biotech

HotSpot Therapeutics

ADARx Pharmaceuticals

Palleon Pharmaceuticals

Econic Biosciences

Design Therapeutics

Simcha Therapeutics

River Renal

Xap Therapeutics

Avenzo Therapeutics

SR One takes a back-and-build approach to its investments. Focusing on companies that we believe have strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases, SR One aims to help reimagine today’s science for tomorrow’s medicines.

SR One’s investing team is situated in key biotechnology hubs on the West Coast, USA and London, UK. Our transatlantic footprint positions SR One as a strategic partner for our portfolio companies, providing geographic reach and regional expertise to mine opportunities and lend business support in real time.

Privacy Policy

Terms & Conditions

SR One

We are on a mission to power the arc of innovation from science to medicine

Our transatlantic presence allows us to access high quality science and opportunities across geographies